Uncategorized

Agenus cancer cocktail records 0% response rate, missing midstage goal

Agenus cancer cocktail records 0% response rate, missing midstage goal

Published

on

An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers Agenus and MiNK Therapeutics aren’t giving up on the program just yet.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version